Delivery Order SPE2DB22D2006-SPE2DB24FW1EE

Award Date 6/18/24
Potential Completion Date 6/20/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,434.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of 4,568,177,973 units of the prescription medication HYSINGLA ER 20 MG TABLET 60S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999.00,...
This federal contract award, valued at $7,177.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hysingla ER 30 mg tablets, a medication used for pain management. This contract is a delivery order and has a firm fixed price pricing type, with an ultimate completion date of January 6, 2025. The contract does not have a set-aside designation, indicating open...
This federal contract award, valued at $1,502.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Hysingla ER Tabs 30mg, a prescription medication, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation and a leading global pharmaceutical distributor. The contract, valued at $1,163.38, is for the delivery of HYSINGLA ER 60 MG TABLET 60S, a specialty pharmaceutical product. This order falls under a larger $999,999,999.00 indefinite delivery contract that AmerisourceBergen Drug Corp holds with DLA to provide a...
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FDXY7, is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,105.69, is for the delivery of HYSINGLA ER 40 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of February 7, 2025 and was awarded on February 6, 2025. It is a Firm Fixed Price contract with no...
This delivery order was awarded by the Defense Logistics Agency Troop Support Medical (DLA) to Amerisourcebergen Drug Corp for the supply of 4561791558 Hysingla ER 40 mg tablets. Under the terms of the firm fixed price contract valued at $758.22, Amerisourcebergen will deliver 60 tablets to a facility located in Conshohocken, Pennsylvania, with performance required between August 11-14, 2023. No major subcontractors or set aside designations were identified. The DLA manages the global supply...
The Defense Logistics Agency Troop Support Medical awarded a $233,930 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 60 bottles of 20mg Hysingla ER tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance is July 12-13, 2023. No additional context was provided regarding the Defense Logistics Agency's programs or any associated contracts. The award information indicates this is a small order for a...
This delivery order for $530 is for the purchase of 4562538879 HYSINGLA ER 40 MG TABLET 60S from Amerisourcebergen Drug Corp. The order was awarded on October 19, 2023 by the Defense Logistics Agency Troop Support Medical to fulfill requirements under an existing prime vendor contract. Performance will take place in Conshohocken, PA with completion by October 20, 2023. No set-aside designation was applied to this firm fixed price order for pharmaceutical products in support of DLA Troop...
The Defense Logistics Agency awarded a $581 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561771228 Hysingla ER 60 mg tablets. As the prime contractor, Amerisourcebergen will deliver 60 count bottles of the hydrocodone bitartrate extended release tablets to a facility in Conshohocken, Pennsylvania between August 10-11, 2023. The order was placed under an existing DLA pharmaceuticals contract vehicle to support the Agency's medical supply needs. No subcontractors or...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Hydromorphone HCL ER 12 MG tablets in 100-count bottles. The contract has a fixed price of $4,192.08 and a completion date of June 11, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW1EE
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,631.74 firm fixed-price contract is for the supply of Hysingla ER 30 mg tablets, a prescription medication.

The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no information provided about any major subcontractors. The DLA, as a defense agency, is responsible for providing logistics, acquisition, and technical services to the U.S. armed forces, other government agencies, and international partners.

Generated 5/17/25, 10:15 AM